Older Patents Get Help As Federal Circuit Sides With Novartis In Gilenya, Everolimus Disputes
Executive Summary
US court finds no obviousness-type double patenting under statute that changed patent term from 17 years from issuance to 20 years from filing; decisions will impact other cases involving patents issued prior to statute.